Reshma Rangwala
Chief Tech/Sci/R&D Officer bei KARYOPHARM THERAPEUTICS INC.
Vermögen: 517 826 $ am 31.03.2024
Aktive Positionen von Reshma Rangwala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.04.2022 | - |
Karriereverlauf von Reshma Rangwala
Ehemalige bekannte Positionen von Reshma Rangwala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 15.09.2020 | 28.03.2022 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 01.05.2017 | 01.07.2020 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.06.2012 | 01.05.2017 |
Ausbildung von Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Börse
- Insiders
- Reshma Rangwala
- Erfahrung
